FDA Explores New Evaluation Framework for Generative AI Medical Devices
The U.S. Food and Drug Administration (FDA) is actively exploring how to evaluate generative AI medical devices, with particular focus on adapting clinician-style testing frameworks for this emerging category of healthcare technology.
As generative AI becomes increasingly integrated into medical applications—from diagnostic assistance to patient communication—the agency